Faint and positive amniotic fluid acetylcholinesterase with a normal sonogram

Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):1000-3. doi: 10.1016/s0002-9378(96)80041-x.

Abstract

Objective: Both faint and positive amniotic fluid acetylcholinesterase determinations have been associated with fetal abnormalities. We evaluated the effect of a normal sonogram and positive or faint acetylcholinesterase level on the risk for anomalies.

Study design: Between Jan. 1, 1989, and Feb. 1, 1995, 4859 amniocenteses were performed. Twenty-three cases of abnormal acetylcholinesterase determinations combined with normal sonograms were identified, and pregnancy outcomes were determined.

Results: One abnormal karyotype was identified (45,X/47,XXX mosaic). No neural tube defects were seen in infants with an abnormal acetylcholinesterase determination and normal sonogram. One fetus of a twin pregnancy had a ventral wall defect that was not detected on ultrasonography. Seventy-three percent of infants were normal at birth, but 27% of the pregnancies had abnormal outcomes.

Conclusions: Advances in ultrasonography have led to improved detection of fetal abnormalities. With a normal karyotype, repeat invasive testing may not be necessary.

MeSH terms

  • Acetylcholinesterase / metabolism*
  • Adult
  • Amniocentesis
  • Amniotic Fluid / enzymology*
  • Congenital Abnormalities
  • Female
  • Humans
  • Karyotyping
  • Pregnancy
  • Pregnancy Outcome
  • Reference Values
  • Risk Factors
  • Ultrasonography, Prenatal*

Substances

  • Acetylcholinesterase